series-c-plus
Stage
2008
Founded
2
Investors
About
Exosome Diagnostics develops molecular diagnostic tests focused on the early detection and risk stratification of aggressive prostate cancer and urologic diseases using personalized genomic assays.
Explore Exosome Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.